Story Navigation
-
DiscoveryDigitalEmerging TechnologyInnovationReimagine MedicineScientific ResearchDrug Development
Drug development gets big data analytics boost
With Nerve Live, Novartis is harnessing the power of data for the benefit of patients.
Discovery -
DiscoveryOncologyWomen in ScienceWorking at NovartisReimagine MedicineCareers
Women in Science: Kristen Harrington-Smith
Kristen Harrington-Smith discusses her work as Vice President and Head of CAR-T US at Novartis Oncology.
Discovery -
DiscoveryDrug DiscoveryInfectious DiseasesInnovationNext Generation ScientistNovartis Institutes for BioMedical Research
Open resources at Novartis help drive innovation
With external help from Novartis, an Argentinian researcher was able to begin his search for a new medicine for tuberculosis.
Discovery -
DiscoveryCancerNovartis Institutes for BioMedical ResearchOncologyTargeted TherapyClinical Research
Immuno-oncology researchers seek to build smart drug combos
Novartis has launched a comprehensive research program to help find the right combinations of therapies for the right patients.
Discovery -
DiscoveryDigitalOncologyWomen in ScienceWorking at NovartisReimagine MedicineCareers
Women in Science: Mimi Huizinga
Meet our Vice President of Strategic Data and Digital at Novartis Oncology.
Discovery -
DiscoveryDigitalDrug DiscoveryInnovationNovartis Institutes for BioMedical ResearchDrug Development
Machine learning poised to accelerate drug discovery
Technology used to tag friends on social media could change the way drug discovery is done.
Discovery -
Discovery
DNA-encoded molecules provide a new edge in cancer drug hunts
Novartis researchers are using new technologies, such as DNA-encoded libraries, to find new ways to treat disease.
Discovery -
DiscoveryCancerDigitalEmerging TechnologyInnovationNovartis Institutes for BioMedical Research
Building “boot camps” for immune cells near tumors
Bioengineers, immunologists and clinicians collaborate to explore a new approach to fighting cancer.
Discovery -
DiscoveryNovartis Institutes for BioMedical ResearchClinical TrialsDrug Development
Taking on obesity
Novartis is developing an experimental drug for weight loss.
Discovery -
DiscoveryBiomedical ResearchDrug DiscoveryLiving With DiseaseNovartis Institutes for BioMedical ResearchClinical Trials
Potential weight loss treatment takes shape with help from patients
Novartis researchers are partnering with advocacy groups to understand the stigma and challenges facing patients with obesity.
Discovery -
DiscoveryDrug DiscoveryNeurodegenerative DiseaseNovartis Institutes for BioMedical ResearchScientific ResearchAlzheimer’s disease
Compound designed to fight Alzheimer’s disease shows promise in the lab
The molecule restores the activity of neurons and neural circuits in a model of the disease.
Discovery -
DiscoveryDigitalEmerging TechnologyInnovationNovartis Institutes for BioMedical ResearchWorking at NovartisClinical Trials
Tracking patients’ progress with radio signals and machine learning
Novartis researchers leverage in-house startup initiative to begin digital technology research collaboration.
Discovery
Pagination
- ‹ Previous page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- …
- 13
- › Next page